Mr Cod,maybe it is more like ADO is blessed with two bows...
The Battery bow, providing the technology is proven ace, would generate revenue quickly due to the competitive environment and lack of regulatory compliance issues.
The diagnostic bow may have a longer lead time due to the regulatory compliance hurdles, -albeit at a lower demand in China.
Recent Presentation and AGM meetings have signified the ramped up interest in POC diagnostics, particularly in China so we may be surprised by the uptake interval.
ADO Board and management are determined to under-promise and overdeliver. Accordingly, there will be zero gloss, we will only be reading the bones, excitement will be withheld. GLTA
